Production of Secretory and Extracellular N-linked Glycoproteins in Escherichia Coli
Overview
Microbiology
Authors
Affiliations
The Campylobacter jejuni pgl gene cluster encodes a complete N-linked protein glycosylation pathway that can be functionally transferred into Escherichia coli. In this system, we analyzed the interplay between N-linked glycosylation, membrane translocation and folding of acceptor proteins in bacteria. We developed a recombinant N-glycan acceptor peptide tag that permits N-linked glycosylation of diverse recombinant proteins expressed in the periplasm of glycosylation-competent E. coli cells. With this "glycosylation tag," a clear difference was observed in the glycosylation patterns found on periplasmic proteins depending on their mode of inner membrane translocation (i.e., Sec, signal recognition particle [SRP], or twin-arginine translocation [Tat] export), indicating that the mode of protein export can influence N-glycosylation efficiency. We also established that engineered substrate proteins targeted to environments beyond the periplasm, such as the outer membrane, the membrane vesicles, and the extracellular medium, could serve as substrates for N-linked glycosylation. Taken together, our results demonstrate that the C. jejuni N-glycosylation machinery is compatible with distinct secretory mechanisms in E. coli, effectively expanding the N-linked glycome of recombinant E. coli. Moreover, this simple glycosylation tag strategy expands the glycoengineering toolbox and opens the door to bacterial synthesis of a wide array of recombinant glycoprotein conjugates.
Recombinant production platform for Group A Streptococcus glycoconjugate vaccines.
Ajay Castro S, Passmore I, Ndeh D, Shaw H, Ruda A, Burns K NPJ Vaccines. 2025; 10(1):16.
PMID: 39843476 PMC: 11754613. DOI: 10.1038/s41541-025-01068-2.
Sotomayor B, Donahue T, Mahajan S, Taw M, Hulbert S, Bidstrup E bioRxiv. 2024; .
PMID: 39574765 PMC: 11580905. DOI: 10.1101/2024.08.12.607630.
Arauzo-Aguilera K, Saaranen M, Robinson C, Ruddock L Microbiologyopen. 2023; 12(2):e1350.
PMID: 37186227 PMC: 9995818. DOI: 10.1002/mbo3.1350.
Moeller T, Shah S, Lai K, Lopez-Barbosa N, Desai P, Wang W ACS Cent Sci. 2023; 9(4):787-804.
PMID: 37122450 PMC: 10141597. DOI: 10.1021/acscentsci.2c01473.
Progress towards a glycoconjugate vaccine against Group A Streptococcus.
Burns K, Dorfmueller H, Wren B, Mawas F, Shaw H NPJ Vaccines. 2023; 8(1):48.
PMID: 36977677 PMC: 10043865. DOI: 10.1038/s41541-023-00639-5.